PTK2 and breast carcinoma: Previous studies using immunohistochemical analyses on tissues samples of patients with EC, colon cancer, breast cancer, and sarcomas compared the expression of FAK proteins in tumor compartments with normal tissues of either the same patients or between different patient cohorts [7, 29, 30].